tetano
Editor, Senior Moderator
J Clin Med
. 2021 Nov 30;10(23):5667.
doi: 10.3390/jcm10235667.
How to Maintain Safety and Maximize the Efficacy of Cardiopulmonary Resuscitation in COVID-19 Patients: Insights from the Recent Guidelines
Dominika Chojecka[SUP] 1 [/SUP], Jakub Pytlos[SUP] 1 [/SUP], Mateusz Zawadka[SUP] 2 [/SUP], Paweł Andruszkiewicz[SUP] 2 [/SUP], Łukasz Szarpak[SUP] 3 4 [/SUP], Tomasz Dzieciątkowski[SUP] 5 [/SUP], Miłosz Jarosław Jaguszewski[SUP] 6 [/SUP], Krzysztof Jerzy Filipiak[SUP] 4 [/SUP], Aleksandra Gąsecka[SUP] 1 [/SUP]
Affiliations
Abstract
Since December 2019, the novel coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has remained a challenge for governments and healthcare systems all around the globe. SARS-CoV-2 infection is associated with increased rates of hospital admissions and significant mortality. The pandemic increased the rate of cardiac arrest and the need for cardiopulmonary resuscitation (CPR). COVID-19, with its pathophysiology and detrimental effects on healthcare, influenced the profile of patients suffering from cardiac arrest, as well as the conditions of performing CPR. To ensure both the safety of medical personnel and the CPR efficacy for patients, resuscitation societies have published modified guidelines addressing the specific reality of the COVID-19 pandemic. In this review, we briefly describe the transmission and pathophysiology of COVID-19, present the challenges of CPR in SARS-CoV-2-infected patients, summarize the current recommendations regarding the algorithms of basic life support (BLS), advanced life support (ALS) and pediatric life support, and discuss other aspects of CPR in COVID-19 patients, which potentially affect the risk-to-benefit ratio of medical procedures and therefore should be considered while formulating further recommendations.
Keywords: COVID-19; CPR; IHCA; OHCA; SARS-CoV-2; cardiac arrest; cardiopulmonary resuscitation.
. 2021 Nov 30;10(23):5667.
doi: 10.3390/jcm10235667.
How to Maintain Safety and Maximize the Efficacy of Cardiopulmonary Resuscitation in COVID-19 Patients: Insights from the Recent Guidelines
Dominika Chojecka[SUP] 1 [/SUP], Jakub Pytlos[SUP] 1 [/SUP], Mateusz Zawadka[SUP] 2 [/SUP], Paweł Andruszkiewicz[SUP] 2 [/SUP], Łukasz Szarpak[SUP] 3 4 [/SUP], Tomasz Dzieciątkowski[SUP] 5 [/SUP], Miłosz Jarosław Jaguszewski[SUP] 6 [/SUP], Krzysztof Jerzy Filipiak[SUP] 4 [/SUP], Aleksandra Gąsecka[SUP] 1 [/SUP]
Affiliations
- PMID: 34884368
- DOI: 10.3390/jcm10235667
Abstract
Since December 2019, the novel coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has remained a challenge for governments and healthcare systems all around the globe. SARS-CoV-2 infection is associated with increased rates of hospital admissions and significant mortality. The pandemic increased the rate of cardiac arrest and the need for cardiopulmonary resuscitation (CPR). COVID-19, with its pathophysiology and detrimental effects on healthcare, influenced the profile of patients suffering from cardiac arrest, as well as the conditions of performing CPR. To ensure both the safety of medical personnel and the CPR efficacy for patients, resuscitation societies have published modified guidelines addressing the specific reality of the COVID-19 pandemic. In this review, we briefly describe the transmission and pathophysiology of COVID-19, present the challenges of CPR in SARS-CoV-2-infected patients, summarize the current recommendations regarding the algorithms of basic life support (BLS), advanced life support (ALS) and pediatric life support, and discuss other aspects of CPR in COVID-19 patients, which potentially affect the risk-to-benefit ratio of medical procedures and therefore should be considered while formulating further recommendations.
Keywords: COVID-19; CPR; IHCA; OHCA; SARS-CoV-2; cardiac arrest; cardiopulmonary resuscitation.